Argenica Therapeutics Limited (AGN.AX)
AUD 0.76
(4.83%)
AUD 0.76
(4.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 2.59 Million AUD | 48.46% |
| 2023 | 1.74 Million AUD | 575.38% |
| 2022 | 259.09 Thousand AUD | -12.49% |
| 2021 | 296.07 Thousand AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 122.75 Thousand AUD | -89.56% |
| 2024 Q4 | 122.75 Thousand AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 1.17 Million AUD | 0.0% |
| 2024 Q1 | 1.17 Million AUD | 532.4% |
| 2023 Q2 | 688.95 Thousand AUD | -0.0% |
| 2023 FY | 1.74 Million AUD | 575.38% |
| 2023 Q4 | 185.99 Thousand AUD | 0.0% |
| 2023 Q3 | 185.99 Thousand AUD | -73.0% |
| 2023 Q1 | 688.95 Thousand AUD | 0.0% |
| 2022 FY | 259.09 Thousand AUD | -12.49% |
| 2022 Q3 | - AUD | -100.0% |
| 2022 Q2 | 129.54 Thousand AUD | 0.0% |
| 2022 Q1 | 129.54 Thousand AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2021 FY | 296.07 Thousand AUD | 0.0% |
| 2021 Q2 | 148.03 Thousand AUD | -0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q1 | 148.03 Thousand AUD | 0.0% |
| 2021 Q3 | - AUD | -100.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -49.496% |
| Acrux Limited | 5.09 Million AUD | 48.97% |
| Actinogen Medical Limited | 9.93 Million AUD | 73.841% |
| AnteoTech Limited | 460.39 Thousand AUD | -464.282% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -15181.982% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 35.363% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 41.655% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -448.608% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -14080.879% |
| Biome Australia Limited | 13 Million AUD | 80.03% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -331.68% |
| BTC Health Limited | 16.36 Thousand AUD | -15779.811% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 65.164% |
| CSL Limited | 22.41 Billion AUD | 99.988% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 77.422% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 97.054% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -12.191% |
| Dimerix Limited | 583.47 Thousand AUD | -345.25% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 96.09% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -107.573% |
| Immuron Limited | 4.9 Million AUD | 47.012% |
| Immutep Limited | 3.5 Million AUD | 25.894% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -114.306% |
| Memphasys Limited | 60 Thousand AUD | -4229.895% |
| Nanollose Limited | 12.5 Thousand AUD | -20681.833% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 98.88% |
| Noxopharm Limited | 2.4 Million AUD | -8.235% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 5.31 Million AUD | 51.124% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | 1.39 Million AUD | -86.344% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -3848.233% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -191.202% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 30.019% |
| PYC Therapeutics Limited | 22.05 Million AUD | 88.223% |
| Race Oncology Limited | 4 Million AUD | 35.108% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -768.213% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 8.28 Million AUD | 68.658% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.477% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -1606.475% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -2636.053% |